Are patient-reported outcomes of physical function a valid substitute for objective measurements?

по Douma, J.A.J., Verheul, H.M.W., Buffart, L.M.
Опубликовано в: Curr Oncol (2018)

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits

по Verheul, H M W, Panigrahy, D, Yuan, J, D'Amato, R J
Опубликовано 1999

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review

по Walraven, Maudy, Witteveen, Petronella O., Lolkema, Martijn P. J., van Hillegersberg, R., Voest, Emile E., Verheul, H. M. W.
Опубликовано 2010

CD133(+) circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

по Vroling, L, Lind, J S W, de Haas, R R, Verheul, H M W, van Hinsbergh, V W M, Broxterman, H J, Smit, E F
Опубликовано 2010

P04.22 Data-driven prioritization and evaluation of novel therapeutic targets in glioblastoma

по Brahm, C G, Walenkamp, A M E, van Linde, M E, Abdul, U K, Westerman, B A, Verheul, H M W, Fehrmann, R S N
Опубликовано в: Neuro Oncol (2018)

The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

по Abou El Hassan, M A I, Verheul, H M W, Jorna, A S, Schalkwijk, C, van Bezu, J, van der Vijgh, W J F, Bast, A
Опубликовано 2003

The assessment of anorexia in patients with cancer: cut-off values for the FAACT–A/CS and the VAS for appetite

по Blauwhoff-Buskermolen, S., Ruijgrok, C., Ostelo, R. W., de Vet, H. C. W., Verheul, H. M. W., de van der Schueren, M. A. E., Langius, J. A. E.
Опубликовано в: Support Care Cancer (2015)

Optimal use of anti-EGFR monoclonal antibodies for patients with advanced colorectal cancer: a meta-analysis

по van Helden, E. J., Menke-van der Houven van Oordt, C. W., Heymans, M. W., Ket, J. C. F., van den Oord, R., Verheul, H. M. W.
Опубликовано в: Cancer Metastasis Rev (2017)

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition

по Nowak-Sliwinska, P, Weiss, A, van Beijnum, J R, Wong, T J, Kilarski, W W, Szewczyk, G, Verheul, H M W, Sarna, T, van den Bergh, H, Griffioen, A W
Опубликовано в: Cell Death Dis (2015)

Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study

по Mammatas, L. H., Zandvliet, A. S., Rovithi, M., Honeywell, R. J., Swart, E. L., Peters, G. J., Menke-van der Houven van Oordt, C. W., Verheul, H. M. W.
Опубликовано в: Cancer Chemother Pharmacol (2020)

Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer

по van Zweeden, A. A., van Groeningen, C. J., Honeywell, R. J., Giovannetti, E., Ruijter, R., Smorenburg, C. H., Giaccone, G., Verheul, H. M. W., Peters, G. J., van der Vliet, Hans J.
Опубликовано в: Cancer Chemother Pharmacol (2018)

Radiomics analysis of pre-treatment [(18)F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment

по van Helden, E. J., Vacher, Y. J. L., van Wieringen, W. N., van Velden, F. H. P., Verheul, H. M. W., Hoekstra, O. S., Boellaard, R., Menke-van der Houven van Oordt, C. W.
Опубликовано в: Eur J Nucl Med Mol Imaging (2018)

MiR expression profiles of paired primary colorectal cancer and metastases by next-generation sequencing

по Neerincx, M, Sie, D L S, van de Wiel, M A, van Grieken, N C T, Burggraaf, J D, Dekker, H, Eijk, P P, Ylstra, B, Verhoef, C, Meijer, G A, Buffart, T E, Verheul, H M W
Опубликовано в: Oncogenesis (2015)

P08.71 Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis

по van Linde, M. E., Brahm, C. G., de Witt Hamer, P. C., Reijneveld, J. C., Bruynzeel, A. M., Wagemakers, M., van der Weide, H. L., Enting, R. H., Verheul, H. M. W., Walenkamp, A. M. E.
Опубликовано в: Neuro Oncol (2016)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis

по Goos, J A C M, Coupe, V M H, Diosdado, B, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Carvalho, B, van den Tol, M P, Verheul, H M W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Опубликовано 2013

[(89)Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

по van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., Menke-van der Houven van Oordt, C. W.
Опубликовано в: Eur J Nucl Med Mol Imaging (2019)

Correction to: [89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

по van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., der Houven van Oordt, C. W. Menke-van
Опубликовано в: Eur J Nucl Med Mol Imaging (2020)